Fujibo Holdings, Inc.
Fujibo Holdings, Inc. (3104.T) Financial Performance & Income Statement Overview
Review Fujibo Holdings, Inc. (3104.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Fujibo Holdings, Inc. (3104.T) Income Statement & Financial Overview
Explore comprehensive income reports for Fujibo Holdings, Inc. 3104.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.72B | $11.13B | $10.68B | $10.38B |
| Cost of Revenue | $7.11B | $7.04B | $7.06B | $6.81B |
| Gross Profit | $3.61B | $4.09B | $3.62B | $3.57B |
| Gross Profit Ratio | $0.34 | $0.37 | $0.34 | $0.34 |
| R&D Expenses | $0.00 | $1.31B | $0.00 | $0.00 |
| SG&A Expenses | $2.12B | $783.00M | $2.17B | $2.02B |
| Operating Expenses | $2.12B | $2.09B | $2.17B | $2.02B |
| Total Costs & Expenses | $9.23B | $9.14B | $9.23B | $8.84B |
| Interest Income | $4.00M | $0.00 | $1.00M | $0.00 |
| Interest Expense | $4.00M | $0.00 | $7.00M | $6.00M |
| Depreciation & Amortization | $957.00M | $867.25M | $867.00M | $867.25M |
| EBITDA | $2.32B | $2.86B | $2.34B | $2.41B |
| EBITDA Ratio | $0.22 | $0.26 | $0.22 | $0.23 |
| Operating Income | $1.49B | $2.00B | $1.45B | $1.55B |
| Operating Income Ratio | $0.14 | $0.18 | $0.14 | $0.15 |
| Other Income/Expenses (Net) | -$171.00M | $275.00M | $21.00M | $35.00M |
| Income Before Tax | $1.32B | $2.27B | $1.47B | $1.58B |
| Income Before Tax Ratio | $0.12 | $0.20 | $0.14 | $0.15 |
| Income Tax Expense | $486.00M | $721.00M | $449.00M | $505.00M |
| Net Income | $833.00M | $1.55B | $1.02B | $1.08B |
| Net Income Ratio | $0.08 | $0.14 | $0.10 | $0.10 |
| EPS | $82.44 | $136.54 | $89.75 | $94.98 |
| Diluted EPS | $82.44 | $136.54 | $89.75 | $94.98 |
| Weighted Avg Shares Outstanding | $10.10M | $11.34M | $11.34M | $11.34M |
| Weighted Avg Shares Outstanding (Diluted) | $10.10M | $11.34M | $11.34M | $11.34M |
Over the last four quarters, Fujibo Holdings, Inc. achieved steady financial progress, growing revenue from $10.38B in Q1 2024 to $10.72B in Q4 2024. Gross profit stayed firm with margins at 34% in Q4 2024 versus 34% in Q1 2024. Operating income totaled $1.49B in Q4 2024, maintaining a 14% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $2.32B. Net income dropped to $833.00M, with EPS at $82.44. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan